Multicenter phase II trial of dose-fractionated irinotecan in patients with advanced colorectal cancer failing oxaliplatin-based first-line combination chemotherapy
Titel:
Multicenter phase II trial of dose-fractionated irinotecan in patients with advanced colorectal cancer failing oxaliplatin-based first-line combination chemotherapy
Auteur:
Ulrich-Pur, H. Kornek, G.V. Fiebiger, W. Gedlicka, C. Raderer, M. Lenauer, A. Depisch, D. Lang, F. Pidlich, J. Scheithauer, W.